Nyxoah (NYXH)

Nyxoah (NYXH) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $121M; returns 1 day +1.5%, 1 week -24.8%, 1 year -85.3%.

Nyxoah S.A. (NYXH) is a Belgium-based medical technology company focused on developing and commercializing innovative neuromodulation solutions for obstructive sleep apnea (OSA). The company's flagship product is the Genio system, a minimally invasive, leadless, and battery-free hypoglossal neurostimulation therapy designed to treat moderate to severe OSA.

Groups NYXH belongs to

• Sleep Apnea
• Medical Devices
• Healthcare
• Minimally Invasive Surgery
• Healthcare Equipment
• Healthcare Technology
• Commercial Stage

NYXH financial model: income statement, cash flow and balance sheet